Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Ipca Laboratories LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:524494NSE Symbol: IPCALABP/E(TTM):37.38
ISIN Demat:INE571A01038Div & Yield %:0.3EPS(TTM):35.79
Book Value(Rs):271.6399623Market Cap ( Cr.):33945.62Face Value(Rs):1
    Change Company 
( In Cr)
 Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
INCOME :      
Sales Turnover 6677.926166.465814.625438.305139.164367.43
Excise Duty0.000.000.000.000.0029.61
Net Sales6677.926166.465814.625438.305139.164337.82
Other Income 71.29111.29111.1952.9262.2464.69
Stock Adjustments -128.4355.19-104.09126.00170.73155.05
Total Income6620.786332.945821.725617.225372.134557.56
EXPENDITURE :      
Raw Materials 1764.882033.571964.941911.881753.211635.75
Power & Fuel Cost235.60253.33277.21237.44201.48196.82
Employee Cost 1479.341336.191193.391102.14948.84870.79
Other Manufacturing Expenses 367.61356.81311.74279.03225.25198.30
Selling and Administration Expenses 953.42846.95812.67612.89551.23523.99
Miscellaneous Expenses 503.13314.87236.31179.67113.31149.41
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure5303.985141.724796.264323.053793.323575.06
Operating Profit1316.801191.221025.461294.171578.81982.50
Interest 65.06122.5846.3410.4111.1318.84
Gross Profit1251.741068.64979.121283.761567.68963.66
Depreciation251.97246.48228.63209.65187.72178.69
Profit Before Tax999.77822.16750.491074.111379.96784.97
Tax340.90288.01223.95197.28244.98137.98
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax8.113.7420.8416.46-5.79-5.47
Reported Net Profit650.76530.41505.70860.371140.77652.46
Extraordinary Items -169.55-69.5217.517.868.3410.86
Adjusted Net Profit820.31599.93488.19852.511132.43641.60
Adjst. below Net Profit -4.92-1.39-2.051.15-0.16-107.04
P & L Balance brought forward4956.804478.524076.353316.312277.181752.53
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 101.4850.74101.48101.48101.4820.77
P & L Balance carried down5501.164956.804478.524076.353316.312277.18
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %400.00400.00400.00400.00400.00250.00
Earnings Per Share-Unit Curr25.6520.9119.9333.9189.9351.64
Earnings Per Share(Adj)-Unit Curr25.6520.9119.9333.9144.9725.82
Book Value-Unit Curr271.64250.24231.66215.84374.67290.11